Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dewi Guellec

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Joint Bone Spine|February 15, 2019
Assessment of major salivary gland size in primary Sjögren's syndrome: Comparison between clinical examination and ultrasonographyPauline Marteau, Divi Cornec, Maelenn Gouillou, et al.
The Lancet. Rheumatology|January 22, 2024
Abatacept in early polymyalgia rheumatica (ALORS): a proof-of-concept, randomised, placebo-controlled, parallel-group trialAlain Saraux, Catherine Le Henaff, Emmanuelle Dernis, et al.
The Lancet. Rheumatology|January 16, 2025
Baricitinib in early polymyalgia rheumatica (BACHELOR): a randomised, double-blind, placebo-controlled, parallel-group trialAlain Saraux, Guillermo Carvajal Alegria, Emmanuelle Dernis, et al.
Rheumatology and Therapy|February 19, 2024
Reliability Exercise of Ultrasound Salivary Glands in Sjögren's Disease: An International Web Training InitiativeBaptiste Quéré, Alain Saraux, Guillermo Carvajal-Alegria, et al.
RMD Open|October 2, 2024
Development of a web-based ecological momentary assessment tool to measure day-to-day variability of the symptoms in patients with Sjögren's diseaseLaurie Georgel, Anas-Alexis Benyoussef, Sofian Berrouiguet, et al.
Rheumatology (Oxford, England)|August 12, 2020
Refining myositis associated with primary Sjögren's syndrome: data from the prospective cohort ASSESSRenaud Felten, Margherita Giannini, Benoit Nespola, et al.
JAMA|September 20, 2022
Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical TrialValérie Devauchelle-Pensec, Guillermo Carvajal-Alegria, Emmanuelle Dernis, et al.
Rheumatology (Oxford, England)|January 11, 2026
The immune cell landscape analyzed by imaging mass cytometry in the muscle of patients with inclusion body myositis associated or not with Sjögren's diseaseBaptiste Quéré, Amélie Bourhis, Patrice Hemon, et al.
Rheumatology (Oxford, England)|March 2, 2024
Inclusion-body myositis associated with Sjögren's disease: clinical characteristics and comparison with other Sjögren-associated myositisQuentin Astouati, Thomas Machet, Camille Houssais, et al.
RMD Open|March 15, 2024
Concordance and agreement between different activity scores in polymyalgia rheumaticaJustine D'Agostino, Aghiles Souki, Anne Lohse, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Joint Bone Spine|February 15, 2019
Assessment of major salivary gland size in primary Sjögren's syndrome: Comparison between clinical examination and ultrasonographyPauline Marteau, Divi Cornec, Maelenn Gouillou, et al.
The Lancet. Rheumatology|January 22, 2024
Abatacept in early polymyalgia rheumatica (ALORS): a proof-of-concept, randomised, placebo-controlled, parallel-group trialAlain Saraux, Catherine Le Henaff, Emmanuelle Dernis, et al.
The Lancet. Rheumatology|January 16, 2025
Baricitinib in early polymyalgia rheumatica (BACHELOR): a randomised, double-blind, placebo-controlled, parallel-group trialAlain Saraux, Guillermo Carvajal Alegria, Emmanuelle Dernis, et al.
Rheumatology and Therapy|February 19, 2024
Reliability Exercise of Ultrasound Salivary Glands in Sjögren's Disease: An International Web Training InitiativeBaptiste Quéré, Alain Saraux, Guillermo Carvajal-Alegria, et al.
RMD Open|October 2, 2024
Development of a web-based ecological momentary assessment tool to measure day-to-day variability of the symptoms in patients with Sjögren's diseaseLaurie Georgel, Anas-Alexis Benyoussef, Sofian Berrouiguet, et al.
Rheumatology (Oxford, England)|August 12, 2020
Refining myositis associated with primary Sjögren's syndrome: data from the prospective cohort ASSESSRenaud Felten, Margherita Giannini, Benoit Nespola, et al.
JAMA|September 20, 2022
Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical TrialValérie Devauchelle-Pensec, Guillermo Carvajal-Alegria, Emmanuelle Dernis, et al.
Rheumatology (Oxford, England)|January 11, 2026
The immune cell landscape analyzed by imaging mass cytometry in the muscle of patients with inclusion body myositis associated or not with Sjögren's diseaseBaptiste Quéré, Amélie Bourhis, Patrice Hemon, et al.
Rheumatology (Oxford, England)|March 2, 2024
Inclusion-body myositis associated with Sjögren's disease: clinical characteristics and comparison with other Sjögren-associated myositisQuentin Astouati, Thomas Machet, Camille Houssais, et al.
RMD Open|March 15, 2024
Concordance and agreement between different activity scores in polymyalgia rheumaticaJustine D'Agostino, Aghiles Souki, Anne Lohse, et al.
Pageof 6